Floatz logo

MERCAPTOPURINE ANHYDROUS

Hodgkin's Disease

Memorial Sloan Kettering Cancer CenterSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Hodgkin's Disease cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 3BBB
PEGFILGRASTIM
Michael Spinner, MD
Phase 3BB
Benadryl
City of Hope Medical Center
Phase 2BB
PENTOSTATIN
St. Jude Children's Research Hospital
Phase 3BB
Basiliximab
City of Hope Medical Center
Phase 2BB

View all 34 →

Same molecule, other indications

MERCAPTOPURINE ANHYDROUS is also rated in:

adult acute lymphoblastic leukemiaDormant
A
Indicative ·
81 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
80 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →